Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16168405 | 0.84 | KDM4E (0.49) | L3MBTL1KDM4EMAOBAOC3MRGPRX4 | |
| SCHEMBL2608844 | 0.83 | KDM4E (0.54) | L3MBTL1KDM4EALDH1A1GAAMAOB | |
| SCHEMBL817449 | 0.82 | KDM4E (0.48) | L3MBTL1KDM4EALDH1A1GAAMAOB | |
| SCHEMBL3148903 | 0.82 | KDM4E (0.48) | L3MBTL1KDM4EALDH1A1GAAMAOB | |
| SCHEMBL817454 | 0.82 | KDM4E (0.48) | L3MBTL1KDM4EALDH1A1GAAMAOB | |
| SCHEMBL817865 | 0.80 | L3MBTL1 (0.51) | L3MBTL1KDM4EALDH1A1GAAMAOB | |
| SCHEMBL4046553 | 0.80 | KDM4E (0.56) | L3MBTL1KDM4EALDH1A1GAAMAOB | |
| SCHEMBL9988187 | 0.80 | HTR2A (0.57) | L3MBTL1KDM4EALDH1A1GAAMAOB | |
| SCHEMBL14227154 | 0.80 | L3MBTL1 (0.51) | L3MBTL1KDM4EALDH1A1GAAMAOB | |
| SCHEMBL19750630 | 0.80 | KDM4E (0.56) | L3MBTL1KDM4EALDH1A1GAAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030514-B2 | Processes and intermediates for the preparations of prostaglandins | CHIROGATE INTERNATIONAL INC. (TW) | 2011-10-04 | — | — | US | disclosed |
| US-20090299088-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF PROSTAGLANDINS | CHIROGLATE INTERNATIONAL INC. | 2009-12-03 | — | — | US | disclosed |
| US-7626024-B2 | Processes and intermediates for the preparations of prostaglandins | Irogate International Inc. (CN) | 2009-12-01 | — | — | US | disclosed |
| US-7582779-B2 | Processes and intermediates for the preparations of prostaglandins | CHIROGATE INTERNATIONAL INC. (TW) | 2009-09-01 | — | — | US | disclosed |
| US-7511168-B2 | Processes and intermediates for the preparations of prostaglandins | Wei, Shih-Yi (TW) | 2009-03-31 | — | — | US | disclosed |
| US-20080039637-A1 | Processes and intermediates for the preparations of prostaglandins | CHIROGATE INTERNATIONAL INC. | 2008-02-14 | — | — | US | disclosed |
| US-20080039627-A1 | Processes and intermediates for the preparations of prostaglandins | CHIROGATE INTERNATIONAL INC. | 2008-02-14 | — | — | US | disclosed |
| US-20070167641-A1 | Processes and intermediates for the preparations of prostaglandins | CHIROGATE INTERNATIONAL INC. | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090299088-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF PROSTAGLANDINS | PTGES, PTGER1, PTGIS | L3MBTL1 4514/4885KDM4E 2828/4885ALDH1A1 1592/4885 |
| US-20070167641-A1 | Processes and intermediates for the preparations of prostaglandins | PTGES, PTGER1, PTGIS | L3MBTL1 4514/4885KDM4E 2828/4885ALDH1A1 1592/4885 |
| US-20080039637-A1 | Processes and intermediates for the preparations of prostaglandins | PTGES, PTGER1, PTGIS | L3MBTL1 4514/4885KDM4E 2828/4885ALDH1A1 1592/4885 |
| US-20080039627-A1 | Processes and intermediates for the preparations of prostaglandins | PTGES, PTGER1, PTGIS | L3MBTL1 4514/4885KDM4E 2828/4885ALDH1A1 1592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.